Zacks Investment Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.25M | Sell |
22,760
-698
| -3% | -$38.4K | 0.01% | 378 |
|
|
2025
Q1 | $1.66M | Buy |
23,458
+3,259
| +16% | +$230K | 0.02% | 350 |
|
|
2024
Q4 | $1.33M | Buy |
20,199
+2,397
| +13% | +$158K | 0.01% | 381 |
|
|
2024
Q3 | $1.25M | Sell |
17,802
-3,771
| -17% | -$265K | 0.01% | 389 |
|
|
2024
Q2 | $1.78M | Buy |
21,573
+1,611
| +8% | +$133K | 0.02% | 306 |
|
|
2024
Q1 | $1.74M | Buy |
+19,962
| New | +$1.74M | 0.02% | 333 |
|
|
2019
Q1 | – | Sell |
-15,183
| Closed | -$1.29M | – | 538 |
|
|
2018
Q4 | $1.29M | Buy |
+15,183
| New | +$1.29M | 0.03% | 302 |
|
|
2016
Q1 | – | Sell |
-4,188
| Closed | -$439K | – | 608 |
|
|
2015
Q4 | $439K | Sell |
4,188
-968
| -19% | -$101K | 0.01% | 439 |
|
|
2015
Q3 | $543K | Sell |
5,156
-19
| -0.4% | -$2K | 0.02% | 413 |
|
|
2015
Q2 | $708K | Buy |
+5,175
| New | +$708K | 0.02% | 369 |
|
|
2014
Q4 | – | Sell |
-10,677
| Closed | -$770K | – | 635 |
|
|
2014
Q3 | $770K | Buy |
10,677
+274
| +3% | +$19.8K | 0.03% | 307 |
|
|
2014
Q2 | $647K | Buy |
+10,403
| New | +$647K | 0.02% | 362 |
|